Q97822159

Summary

Q97822159 is an individual motion^[1].

Key Facts

• Q97822159 authored Agneta Luttropp^[2].
• Q97822159 authored Jan Lindholm^[3].
• Q97822159's instance of is recorded as individual motion^[4].
• Q97822159's part of the series is recorded as motions of the 2010-2011 legislative session of the Riksdag^[5].
• Q97822159's language of work or name is recorded as Swedish^[6].
• Q97822159's publication date is recorded as +2010-10-23T00:00:00Z^[7].
• Q97822159's main subject is recorded as medication^[8].
• Q97822159's work available at URL is recorded as http://data.riksdagen.se/dokument/GY02So325^[9].
• Q97822159's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GY02So325^[10].
• Q97822159's applies to jurisdiction is recorded as Sweden^[11].
• Q97822159's legal citation of this text is recorded as Mot. 2010/11:So325^[12].
• Q97822159's title is recorded as Lex Gulli mot läkemedelsvanvård^[13].
• Q97822159's maintained by WikiProject is recorded as Project Riksdagen's documents^[14].
• Q97822159's copyright status is recorded as public domain^[15].
• Q97822159's legislative committee is recorded as Committee on Health and Welfare^[16].
• Q97822159's Swedish Riksdag document ID is recorded as GY02So325^[17].

Body

Works and Contributions

Authored works include Agneta Luttropp^[2], a politician^[18], b. 1945^[19], of Sweden^[20] and Jan Lindholm^[3], a politician^[21], b. 1951^[22], of Sweden^[23].